Gritstone bio Inc. (NASDAQ: GRTS)
$0.70
-0.0094 ( -1.32% ) 53.8K
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
Market Data
Open
$0.70
Previous close
$0.71
Volume
53.8K
Market cap
$76.43M
Day range
$0.68 - $0.71
52 week range
$0.52 - $3.33
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 26, 2024 |
8-k | 8K-related | 13 | Jun 25, 2024 |
8-k | 8K-related | 13 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |